India's Covid-19 cases cross 5,000-mark, Kerala, Delhi, Bengal most affected
advertisementMaharashtra reported 114 new Covid-19 cases on Friday, bringing the total to 1,276 cases since January, along with one more death, raising the toll to 18. Pune (44 cases) and Mumbai (37 cases) reported the highest numbers, followed by Mira Bhayandar and Panvel with seven cases each.
In the last 24 hours, West Bengal reported 58 new Covid-19 cases and 91 recoveries. The total active cases now stand at 596, with the death toll remaining at one.
advertisement
Delhi reported 30 new Covid-19 cases, raising active infections to 592, with no new deaths since Thursday, keeping the total fatalities at seven since January 1.
Chhattisgarh has reported 50 Covid-19 cases following recent screenings conducted in response to a rise in infections in other parts of the country, officials said on Friday. Additionally, 1,183 people were tested after the detection of a new variant, and 50 tested positive for the virus.
Haryana reported 31 new Covid-19 cases on Friday, with Gurugram (9) and Faridabad (11) accounting for the majority. Other cases were reported from Karnal, Jhajjar, Panipat, Yamunanagar, Hisar and Panchkula. The state currently has 87 active cases and a total of 151 cumulative cases.
Officials state that most cases are mild and managed at home. Scientists add that while Covid-19 is becoming milder, occasional surges may happen since the virus is now endemic and constantly evolving. They added that there is no cause for alarm.
On June 5, hospitals across the country conducted a mock drill to assess their preparedness for handling Covid-19 cases. The central government has directed all states to ensure adequate availability of oxygen, ventilators, isolation beds and essential medicines to manage a possible Covid-19 surge.
On June 2 and 3, a series of technical review meetings chaired by Dr. Sunita Sharma, DGHS, were held with key health and disaster management agencies and state representatives. The purpose was to assess the current Covid-19 situation and review preparedness measures.
Authorities are closely monitoring Influenza Like Illness (ILI) and Severe Acute Respiratory Illness (SARI). Testing is conducted for all admitted SARI cases and for 5 percent of ILI cases according to guidelines. Positive SARI samples are sent for Whole Genome Sequencing through the ICMR VRDL network.
The World Health Organisation officially ended Covid-19's status as a public health emergency in May 2023. Health experts now describe the disease as seasonal, endemic, persistent, or limited to specific regions.
Tune InMust Watch
IN THIS STORY#Covid-19
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
15 minutes ago
- Time of India
Covid variant XFG surges 14% in US as WHO tracks spread to 38 nations, India confirms 163 cases; here's what we know so far
The United States is reporting a steady increase in Covid-19 cases linked to the XFG variant, now the country's third-most common strain this summer. Also known as 'Stratus,' XFG is a recombinant of two earlier Omicron subvariants—LF.7 and LP.8.1.2—first identified in Southeast Asia in January 2025. The World Health Organization (WHO) has placed XFG under its 'variant under monitoring' category. This means that while it is not considered a major health threat at present, its spread is being closely tracked. Global and national spread Data from the US Centers for Disease Control and Prevention (CDC) shows that XFG represented 0 per cent of US cases in March, rising to 2 per cent in April, 6 per cent in May, and 14 per cent by late June. This puts it behind only two other variants in prevalence. The variant has also been reported in several European nations. WHO figures indicate its global share rose from about 7 per cent in early May to 22.7 per cent by late June, spanning at least 38 countries. ⚠️ BREAKING: COVID-19 Cases Rising in 25 US States, Including California, Florida, and Texas, Signaling Onset of 'Summer Wave' In India, the Indian SARS-CoV-2 Genomics Consortium (Insacog) recorded 163 confirmed cases of XFG by the end of June. Symptoms and health impact So far, XFG does not appear to cause symptoms different from or more severe than those seen with other Omicron strains. Variants like XFG can develop when a person is infected with two versions of the virus simultaneously, allowing genetic material to mix. Reported symptoms include: Fever or chills Cough Shortness of breath or breathing difficulty Sore throat Nasal congestion or runny nose New loss of taste or smell Fatigue Muscle or body aches Headache Nausea or vomiting The CDC advises immediate medical help for chest pain, confusion, difficulty staying awake, or pale/blue lips, skin, or nail beds. Expert assessment and vaccination guidance WHO and expert evaluations confirm that: Public health risk remains low No evidence of increased severity Current vaccines continue to protect against symptomatic and severe illness Precautionary measures Health authorities recommend the following steps: Get tested if symptoms appear Stay home if unwell Maintain good hygiene practices Keep vaccinations and boosters up to date While XFG is spreading quickly, current evidence suggests that with routine precautions and existing vaccination coverage, the impact can be managed effectively. To stay updated on the stories that are going viral follow Indiatimes Trending.
Time of India
15 minutes ago
- Time of India
COVID wave is moving across USA: Health experts warn parents that children must do this
Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads FAQs Tired of too many ads? Remove Ads United States of America is witnessing a late-summer COVID wave, even as children are preparing to return to school. Fortunately, hospitalization rates remain low. The risk of severe illness and hospitalization among children younger than 1 who are infected with the coronavirus is comparable to that among adults 65 and older. That's why experts have said that a child's first exposure should be through a vaccine, rather than infection. However, this fall, it may not be possible for many parents to have a healthy child younger than age 5 immunized against COVID, as per a health experts noted that the coronavirus is still a threat, even for otherwise healthy children younger than 2. Among children ages 6 months to 2 years who were hospitalized with COVID from October 2022 to April 2024, more than half had no underlying medical conditions, according to data from the CDC, NYT News Service reported. Pfizer 's vaccine has long been available to these children under so-called emergency use authorization. But the Food and Drug Administration is considering discontinuing the authorization for that age group, according to an email sent by the Centers for Disease Control and Prevention to state and local health confirmed the possibility Monday evening and said that the company was "currently in discussions with the agency on potential paths forward." For children 5 to 11 years old, the Pfizer vaccine is expected to be approved and available, according to the CDC's email, which was reviewed by The New York July, the FDA granted full approval to Moderna's COVID vaccine for children -- but only for those who have health conditions that may put them at increased risk should they become infected. Novavax's COVID vaccine has never been available for children younger than upshot is that if the FDA does not renew Pfizer's authorization for children 6 months to 4 years, or fully approve the vaccine, healthy children in that age group will have no officially sanctioned options -- although doctors may still choose to provide the vaccine "off label."In May, Health Security Robert F. Kennedy Jr. announced that COVID vaccines would no longer be offered to healthy children or pregnant women. Kennedy has called the Pfizer and Moderna vaccines dangerous. In May 2021, in the thick of the pandemic, he filed a petition with the FDA demanding that the agency revoke authorization for the CDC, which typically makes such recommendations, later walked back the secretary's statement, saying that healthy children could get the shot if a doctor agreed that it was told the CDC it was ramping up supplies of its vaccine for the fall, according to the agency's email. But it is not approved for healthy children, and if the FDA rescinds authorization for children younger than 5, parents of healthy children will find themselves with no Nixon, a spokesperson for the Department of Health and Human Services, declined to comment on potential regulatory changes and said any reports before an official statement should be treated as "speculation."But public health experts noted that the coronavirus is still a threat, even for otherwise healthy children younger than 2. Among children ages 6 months to 2 years who were hospitalized with COVID from October 2022 to April 2024, more than half had no underlying medical conditions, according to data from the vaccines have also been shown to offer modest protection against long COVID in some children. The effects are already becoming apparent. Providers have stopped ordering last year's shot, as they often do at this time of the year. Normally by this point, there would be a clear plan for the 2025-26 season.A1. The full form of CDC is Centers for Disease Control and Prevention.A2. Full form of FDA is Food and Drug Administration.
Time of India
an hour ago
- Time of India
New Covid ‘Stratus' variant now the third most common in US: Symptoms, spread and response
Covid cases growing in most states Live Events 'Stratus' variant becomes more prominent WHO risk assessment and vaccine effectiveness Covid 'Stratus' variant: Symptoms and public advice Concerns over vaccine policy changes (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel The United States is seeing a rise in Covid-19 activity, with the sharpest increases recorded in the west. The Centres for Disease Control and Prevention (CDC) says that nationwide wastewater virus levels have climbed from 'low' to 'moderate' in the past highest readings are concentrated in Alaska, California, Colorado, Nevada and Utah, all classified as 'high'. Louisiana leads in the southeast, where levels are also elevated.'Wastewater monitoring can detect viruses spreading from one person to another within a community earlier than clinical testing and before people who are sick go to their doctor or hospital,' the CDC says. 'It can also detect infections without symptoms. If you see increased wastewater viral activity levels, it might indicate that there is a higher risk of infection.'Wastewater surveillance is being used as an early-warning system for new waves, with California's own data now showing higher levels than during last winter's of Tuesday, the CDC estimates cases are rising or likely rising in 45 states, up from 40 last week. Only Alaska, North Dakota, Maine and New Hampshire showed no change. Wyoming's trend was not the pace of increase is slower than in past surges, health officials say immunity from previous infections and vaccinations varies widely, making it hard to predict how severe the current wave could XFG variant, nicknamed 'Stratus,' is now the third most common strain in the US this summer. First detected in Southeast Asia in January, it went largely unnoticed in America until May. By late June it accounted for 14 per cent of cases, behind NB.1.8.1 and is a combination of the F.7 and LP.8.1.2 variants, the latter being the second most prevalent in the country. It carries mutations that may help it evade immune defences, though scientists say it is less likely to be highly contagious than other dominant strains.'There is currently no clear evidence that XFG causes more severe disease or significantly different symptoms than earlier Omicron variants,' said Subhash Verma, professor of microbiology and immunology at the University of Nevada, Reno. 'Importantly, there are no immediate public health concerns associated with this variant.'In June, the World Health Organization placed XFG on its watchlist but rated its global public health risk as low. 'Currently approved COVID-19 vaccines are expected to remain effective to this variant against symptomatic and severe disease,' the WHO said in its June CDC's shift to longer reporting timeframes is partly due to lower data submissions from states, which means the real spread may be higher than official CDC lists the common Covid-19 symptoms as fever or chills, cough, shortness of breath, sore throat, congestion, loss of taste or smell, fatigue, muscle aches, headache, nausea or vomiting. Hoarseness has been reported anecdotally with XFG, though there is no confirmed are advised to seek urgent medical attention for breathing difficulties, persistent chest pain, confusion, inability to wake, or changes in skin colour such as pale, grey or blue lips and nail increase in cases comes shortly after the US Department of Health and Human Services announced it will terminate 22 federal contracts for mRNA-based vaccines. The move has sparked debate about the future of a technology credited with saving millions of lives during the a CBS interview in July, physician Jon LaPook said the pattern of rising summer cases is now familiar. 'We now know that there's a winter spike and then there's a summer spike,' he said. 'And every year, the number of deaths, the number of hospitalisations, is gradually going down each season. So that's the good news.'However, experts say it is still too soon to tell how big the late-summer wave will be, especially with changes to vaccine recommendations and varying levels of immunity across the population.
